Warm-toned photograph of a stethoscope resting on a wooden desk beside medical charts, conveying a serious healthcare setting

A national public affairs campaign launched by the American College of Cardiology in December 2009 to oppose Medicare physician fee schedule cuts affecting cardiology patients and practices.

About the Campaign

The Campaign for Patient Access was launched by the American College of Cardiology in December 2009 as a national effort to reverse Medicare physician fee schedule cuts that threatened cardiovascular care. The site provided background on the issue, the ACC's legislative and legal response, resources for patients and practices, a newsroom tracking coverage across the country, and ways for supporters to share their stories and support the campaign.

From the Newsroom

Capitol building dome against a pale sky, conveying federal policy and legislative action
April 30, 2010

Medicare Meltdown: Access to Health Care in "Critical Condition"

A press release warning that cardiology access was in critical condition due to Medicare payment cuts.

Read more
Gavel on a dark wooden bench in a courtroom setting, suggesting legal proceedings
December 29, 2009

Cardiology Takes Legal Action Against Medicare

The ACC filed suit against HHS Secretary Kathleen Sebelius over the 2010 Physician Fee Schedule.

Read more
A stack of newspapers with a muted gray and off-white palette, suggesting breaking health policy news
January 12, 2010

ACC Statement on Health Care Reform

The ACC used the State of the Union address to highlight the need to reverse the Medicare cuts.

Read more
A wide shot of a diverse group of healthcare professionals and advocates gathered around a conference table, deep in discussion
April 12, 2010

Medicare Patients and Physicians Join Petition Drive

Patients and physicians in Washington, DC joined a petition drive calling on Congress for Medicare reform.

Read more

How Payment Cuts Can Limit Anticoagulation Care

Anticoagulant medicines help prevent dangerous blood clots in people with atrial fibrillation, venous thromboembolism, mechanical heart valves, and other cardiovascular conditions. These medicines can be lifesaving, but safe treatment depends on much more than a prescription. Patients often need risk assessments, laboratory testing, dose adjustments, medication reviews, and timely communication with a cardiology team.

When Medicare physician payments are reduced, the effect can reach these essential services even when the price of the medication itself does not change. Practices may have less capacity to operate anticoagulation clinics, monitor patients between visits, and respond quickly when a patient experiences bleeding, misses doses, or starts another medication.

Access to cardiovascular care is shaped by staffing, appointment availability, technology, and transportation as well as by clinical expertise. Understanding how payment policy affects each part of anticoagulation management helps patients, physicians, and policymakers recognize the stakes.

Why Anticoagulation Requires Ongoing Clinical Support

Anticoagulants have a narrow margin between benefit and harm. Too little medication may leave a patient vulnerable to stroke or another clot. Too much can increase the risk of serious bleeding. The appropriate treatment can also change as kidney function, weight, age, diet, health status, and other medications change.

Warfarin illustrates the need for regular supervision. Patients taking it may require repeated international normalized ratio, or INR, tests and dose adjustments. Direct oral anticoagulants, including apixaban, rivaroxaban, dabigatran, and edoxaban, do not usually require routine INR testing, but they still require periodic evaluation of kidney function, adherence, drug interactions, bleeding symptoms, and dosing.

Anticoagulation services connect these tasks into a coordinated process. Nurses, pharmacists, medical assistants, physicians, and laboratory staff may all contribute. A patient who cannot reach the office quickly may delay care, misunderstand instructions, or stop treatment without guidance.

How Physician Payment Reductions Ripple Through Care

A Medicare fee schedule reduction does not necessarily reduce the retail cost of an anticoagulant. Its effect is more indirect: it can reduce the resources available to provide the professional services that make anticoagulant therapy safe. A practice facing lower reimbursement may need to manage more patients with fewer staff hours or may have difficulty maintaining specialized programs.

Some practices may reduce appointment capacity, consolidate anticoagulation monitoring with other visits, or limit same-day clinical support. Others may postpone investments in electronic monitoring, telehealth, patient outreach, or care coordination. These decisions can make routine follow-up less convenient and urgent questions harder to resolve.

The impact may be particularly serious for independent cardiology practices and clinics serving rural or underserved communities. A large health system may have more ability to absorb a payment change, while a smaller practice may depend on each reimbursed service to support its clinical workforce. If a local practice closes or stops accepting Medicare patients, the nearest alternative could be many miles away.

Where Patients Feel the Difference

Access problems often appear gradually. A patient may wait longer for an appointment, spend more time traveling for laboratory testing, or struggle to obtain a prompt response about a missed dose. Each inconvenience can become a clinical risk when it delays a decision about continuing, holding, or changing anticoagulant therapy.

Patients with limited transportation, mobility challenges, language barriers, or unreliable internet access face additional obstacles. Older adults may need help organizing multiple prescriptions and recognizing signs of internal bleeding. People with limited income may also skip follow-up appointments or laboratory testing when those services involve transportation costs, copayments, or time away from work.

Disruptions can also affect transitions between care settings. After a hospitalization, a patient may leave with a new anticoagulant prescription and instructions that differ from a previous regimen. Timely communication between the hospital, cardiologist, primary care clinician, pharmacy, and patient is essential. Reduced practice capacity can make these handoffs less reliable.

The Difference Between Supported and Strained Care

The following comparison shows how payment pressure can influence the delivery of anticoagulation management. These are care patterns rather than fixed outcomes; practices vary, and many clinicians continue to protect essential services under difficult financial conditions.

Area of care Adequately supported service Service under financial pressure
Follow-up scheduling Regular visits based on clinical risk and treatment needs Longer waits or fewer dedicated monitoring appointments
Laboratory coordination Convenient INR testing and prompt review of results Delayed testing, fragmented communication, or added travel
Medication review Routine checks for interactions, adherence, kidney function, and bleeding Medication questions addressed less consistently
Patient education Repeated counseling using accessible language and interpreters when needed Shorter conversations and less follow-up reinforcement
Care transitions Clear communication after hospitalization or emergency treatment Greater risk of duplicated, interrupted, or misunderstood instructions
High-risk patients Outreach when appointments or tests are missed Reliance on patients to initiate contact
Practice capacity Nurses, pharmacists, and support staff available for coordination Fewer staff members managing larger patient panels

Payment policy can therefore influence quality through operational decisions. A practice may preserve physician visits while reducing the unbillable coordination work that surrounds them. Yet that coordination often prevents avoidable complications and helps patients remain on the right treatment plan.

Clinical Consequences of Delayed Monitoring

When anticoagulation support is difficult to access, patients may experience preventable interruptions or unsafe continuation of therapy. Someone with an elevated INR may not receive timely dose instructions. A person taking a direct oral anticoagulant may not realize that worsening kidney function requires a medication review. Another patient may stop treatment after bruising without understanding the difference between a minor side effect and an emergency warning sign.

Delayed access can also complicate procedures and surgery. Patients may need individualized instructions about when to pause an anticoagulant and when to restart it. Those decisions depend on the reason for anticoagulation, the risk of clotting, the procedure, kidney function, and sometimes the use of bridging therapy. Generic advice cannot safely replace clinician guidance.

Emergency departments and hospitals may bear the consequences when outpatient support is unavailable. A patient who cannot reach a cardiology office may seek emergency care for a medication question or wait until a manageable problem becomes a serious bleeding event. That shift can increase costs while placing additional pressure on already busy health systems.

Protecting Continuity Across Communities

Maintaining access requires recognizing anticoagulation management as a continuing service rather than a single office visit. Payment systems should support the clinical labor involved in reviewing results, contacting patients, coordinating with pharmacies, and managing treatment changes. Adequate reimbursement can help practices retain trained staff and preserve programs that keep high-risk patients connected to care.

Technology can help, but it is not a complete substitute for clinical capacity. Home INR testing, remote visits, electronic reminders, and patient portals may reduce travel and improve communication for some people. They require investment, technical support, broadband access, and alternatives for patients who are not comfortable or able to use digital tools.

Cardiology practices, primary care offices, hospitals, and community organizations can also strengthen referral pathways. Shared records, clear discharge instructions, and direct communication between clinicians reduce confusion. These efforts are more sustainable when reimbursement recognizes the time and expertise needed to coordinate them.

Steps That Help Patients Stay Safely Connected

Patients and caregivers can take practical steps while broader payment and access policies are being addressed:

  • Keep an up-to-date list of every prescription, over-the-counter medicine, and supplement, and share it with each clinician and pharmacist.
  • Attend recommended laboratory tests and medication reviews, even when treatment feels stable.
  • Ask the care team what to do after a missed dose, before a procedure, or when another clinician prescribes a new medicine.
  • Learn the warning signs that require urgent attention, including unusual bleeding, black or bloody stools, severe headache, weakness, chest pain, or sudden shortness of breath.
  • Report transportation, cost, language, or scheduling barriers early so the practice can identify available support.

Patients should never change or stop an anticoagulant without professional advice unless emergency personnel instruct them to do so. Keeping appointments and communicating promptly are important, but those actions depend on having an accessible care team. Policy decisions that preserve cardiology staffing and monitoring capacity make safe adherence more realistic.

Making Access Part of the Policy Conversation

The effect of physician payment cuts should be evaluated through the patient experience, not only through a budget line. Policymakers should consider whether Medicare beneficiaries can obtain timely anticoagulation monitoring, medication counseling, laboratory review, and post-hospital follow-up. Measures of access should include rural distance, appointment delays, staffing shortages, and the needs of patients with complex cardiovascular disease.

Physicians and patients can add valuable evidence to this discussion. A practice’s experience with reduced monitoring capacity, longer waits, or fewer outreach calls shows how reimbursement policy affects care in real communities. A patient’s account of traveling hours for an INR test or being unable to reach a clinician after a medication change gives a human dimension to an otherwise abstract policy debate.

Protecting access to anticoagulation services supports stroke prevention, bleeding safety, and continuity of cardiovascular care. Share experiences with professional organizations, communicate with elected representatives, and support policies that recognize the full work required to manage anticoagulant therapy. Patient stories and clinician evidence can help preserve the services that heart patients rely on every day.

A close-up of a handwritten letter on paper beside a pen, warm natural light, soft cream and muted gray tones

Share Your Story

Tell us how Medicare cuts affected access to cardiovascular care. Stories could be reviewed and submitted to local news outlets as part of the campaign's outreach.